Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. beacon
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Beacon Articles & Analysis

16 news found

Dosimetry monitoring with the RiumBox: Protect the health of healthcare workers in hospital settings

Dosimetry monitoring with the RiumBox: Protect the health of healthcare workers in hospital settings

In this context, they chose to equip themselves with the RiumBox developed by Bertin Technologies within their infrastructures, enabling more precise management of ambient dosimetry and the downgrading of personnel. As a result, 28 beacons have been installed in various departments (radiology, operating theatres, and scanners rooms), enabling real-time monitoring of ionizing ...

ByBertin Technologies


New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

New Potential In Lung Fibrosis Treatment With Lung Cell Transplantation

However, a recent study by Milman-Krentsis (2024) offers a beacon of hope, demonstrating the potential of lung cell transplantation as a therapeutic intervention for lung fibrosis. ...

BySCIREQ - an emka TECHNOLOGIES Company


Vantage Welcomes Roczen!

Vantage Welcomes Roczen!

We are delighted to welcome Roczen to the community of healthcare organisations leveraging Vantage Software! We look forward to working together and helping them deliver exceptional care and support to those living with chronic conditions. Book a Free Demo ...

ByVantage Software


Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research

Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research

However, due to their scarcity and diversity, research in this area has been traditionally challenging, making this development a beacon of hope for patients and researchers worldwide. After decades of intense scientific research into developing gene editing technologies, despite several obstacles, gene therapy for rare diseases has fostered several successful instances recently. ...

ByProtheragen


Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference

Research from Beacon Biosignals Presented at Alzheimer`s Association International Conference

Beacon Biosignals, a startup that applies AI to EEG to unlock precision medicine for neurological and psychiatric disorders, presented research at the Alzheimer's Association International Conference, which took place July 31–Aug. 4, 2022, in San Diego. ...

ByBeacon Biosignals, Inc.


Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation's leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon's machine learning neuroanalytics platform. ...

ByBeacon Biosignals, Inc.


Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo

Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo

The Company will also feature its Beacon® platform technology and workflows in booth #514 for attendees to explore with hands-on demonstrations. ...

ByBruker Corporation


Lyra Therapeutics Announces Initiation Of Lyr-210 Pivotal Phase 3 Enlighten Program In Surgically Naïve Chronic Rhinosinusitis Patients

Lyra Therapeutics Announces Initiation Of Lyr-210 Pivotal Phase 3 Enlighten Program In Surgically Naïve Chronic Rhinosinusitis Patients

For the Company's second product candidate, LYR-220 for the treatment of adult patients with CRS who have had a prior surgery for their CRS symptoms, the BEACON Phase 2 trial has been initiated. The BEACON trial is a controlled, randomized, parallel-group study to evaluate safety, tolerability, pharmacokinetics, and efficacy comparing 2 designs of LYR-220 to ...

ByLyra Therapeutics, Inc.


Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium

Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy Tests in Gastrointestinal Cancers at ASCO GI Cancers Symposium

” Full List of Guardant Health Presentations: Impact of postoperative integrated genomic and epigenomic signatures of circulating tumor DNA (ctDNA) on recurrence in resected colorectal cancer: Initial report of a prospective ctDNA monitoring study COSMOS-CRC-01 (Abstract 168) Clinical utility of microsatellite instability (MSI-H) identified on liquid biopsy in advanced gastrointestinal ...

ByGuardant Health, Inc.


Lyra Therapeutics to Highlight LYR-210 and LYR-220 Clinical Programs at Virtual Event with Leading Clinical CRS Experts

Lyra Therapeutics to Highlight LYR-210 and LYR-220 Clinical Programs at Virtual Event with Leading Clinical CRS Experts

During the virtual event, Lyra management will also provide an update on the upcoming Phase 2 BEACON study of LYR-220 and upcoming Phase 3 ENLIGHTEN program for LYR-210. ...

ByLyra Therapeutics, Inc.


Lyra Therapeutics Presents New Positive Phase 2 LANTERN 6-Month Follow-Up and LYR-210 Pharmacokinetic Data, and LANTERN Manuscript Wins Award at the 67th Annual Meeting of the American Rhinologic Society

Lyra Therapeutics Presents New Positive Phase 2 LANTERN 6-Month Follow-Up and LYR-210 Pharmacokinetic Data, and LANTERN Manuscript Wins Award at the 67th Annual Meeting of the American Rhinologic Society

We look forward to advancing the clinical development of LYR-210, and our second candidate, LYR-220 for post-surgical CRS patients, into the Phase 3 ENLIGHTEN program and Phase 2 BEACON program, respectively, around the end of this year." LANTERN Study and 6-Month Post-Treatment Safety Follow-up In the Phase 2, multicenter, blinded, randomized, controlled, dose-ranging LANTERN ...

ByLyra Therapeutics, Inc.


Announcing a New Leadership Team at Vave Health

Announcing a New Leadership Team at Vave Health

Murph previously held various roles at both Fortune 100 companies and small startups, having helped two companies raise over $20M in funding and also facilitating Health Beacons to an exit. Karin’s experience working across a broad array of industries in designing scalable outcome-based operating models will help bring Vave’s ‘full stack’ tech company to ...

ByVave Health, Inc.


Population Bio Recognizes World Rare Disease Day 2017 with a Commitment to Provide New Insights into Rare Diseases

Population Bio Recognizes World Rare Disease Day 2017 with a Commitment to Provide New Insights into Rare Diseases

Melville, NY, (February 28, 2017) Population Bio (PB) – a global leader in gene discovery announced, in support of World Rare Disease Day, its continued investment in its CNV Beacon® gene discovery platform which delivers new knowledge about rare diseases. The CNV Beacon® platform can discern subtypes of common diseases such as Parkinson’s ...

ByPopulation Bio, Inc. a Precision Medicine Company


New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations

New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations

www.clinicaltrials.gov/ct2/show/NCT01529632?term=BEACON&rank=6 www.clinicaltrials.gov/ct2/show/NCT01709903?id=01709903&rank=1 Spiriva Medical Review Part 2. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-395_Spiriva.cfm Advair Medical Review. www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021077_S003_ADVAIR_DISKUS.pdf et al. ...

ByNovartis International AG


McCarthy Building Companies to Begin Major Structural Work on Torrance Memorial Medical Center Replacement Tower

McCarthy Building Companies to Begin Major Structural Work on Torrance Memorial Medical Center Replacement Tower

“Once completed, the tower will be unmatched locally in its energy and environmental design efficiencies. It will truly be a beacon for wellness and sustainability.” McCarthy is the general contractor for the 256-bed replacement project, which began construction in February 2010. ...

ByMcCarthy Tetrault


Six local programs win 2010 afterschool innovator awards

Six local programs win 2010 afterschool innovator awards

This year's Afterschool Innovator Awards were presented to: The Cypress Hills/East New York (CHENY) Beacon Program in Brooklyn, New York, for providing multiple benefits to middle school students, including service opportunities and leadership and social development; The Junior ACE Program in Sacramento, California, for providing pathways to higher education and careers for ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT